# Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy

> **NCT03702374** · PHASE3 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 132 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Combined antioxidant therapy
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03702374
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-26
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2022-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702374, "Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03702374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*